Edition:
India

Insider Trading: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

77.77USD
2:29am IST
Change (% chg)

$0.70 (+0.91%)
Prev Close
$77.07
Open
$77.60
Day's High
$78.28
Day's Low
$76.45
Volume
389,166
Avg. Vol
468,080
52-wk High
$100.13
52-wk Low
$62.89

All Insider Trades
Trading Date Name Title Type Shares Traded Price
25 Oct 2019

Bienaime (Jean-Jacques)

Chief Executive Officer Buy 5,000 $21.51
25 Oct 2019

Bienaime (Jean-Jacques)

Chief Executive Officer Sell 5,000 $69.55
27 Sep 2019

Bienaime (Jean-Jacques)

Chief Executive Officer Buy 1,000 $21.51
17 Sep 2019

Lawlis (V. Bryan Jr)

Director Sell 3,750 $74.47
17 Sep 2019

Lawlis (V. Bryan Jr)

Director Buy 3,750 $21.51
7 Aug 2019

Heron (Elaine J)

Director Buy 1,553 $63.10
9 Jul 2019

Anderson (Elizabeth M)

Director Buy 4,490 $0.00
17 Jun 2019

Lawlis (V. Bryan Jr)

Director Sell 3,750 $81.08
17 Jun 2019

Lawlis (V. Bryan Jr)

Director Buy 3,750 $21.51
11 Jun 2019

Meier (Richard A)

Director Gift 6,000 $0.00
5 Jun 2019

Ajer (Jeffrey Robert)

Officer Buy 14,160 $0.00
5 Jun 2019

Davis (George Eric)

General Counsel Gift 300 $0.00
5 Jun 2019

Baffi (Robert A)

Officer Buy 14,160 $0.00
4 Jun 2019

Dere Willard H

Director Buy 4,430 $0.00
4 Jun 2019

Slamon (Dennis J)

Director Buy 4,430 $0.00
4 Jun 2019

Meier (Richard A)

Director Buy 4,430 $0.00
4 Jun 2019

Heron (Elaine J)

Director Buy 4,430 $0.00
4 Jun 2019

Pyott (David E I)

Director Buy 4,430 $0.00
4 Jun 2019

Lawlis (V. Bryan Jr)

Director Buy 4,430 $0.00
4 Jun 2019

Lewis (Alan J. Ph.D.)

Director Buy 4,430 $0.00
4 Jun 2019

Grey (Michael G.)

Director Buy 4,430 $0.00
4 Jun 2019

Hombach (Robert J)

Director Buy 4,430 $0.00
10 May 2019

Bienaime (Jean-Jacques)

Chief Executive Officer Sell 10,000 $82.52
10 May 2019

Bienaime (Jean-Jacques)

Chief Executive Officer Buy 10,000 $14.39
9 May 2019

Bienaime (Jean-Jacques)

Chief Executive Officer Buy 4,000 $14.39

Institutional Holders

% Shares Owned: 98.80%
# of Holders: 678
Total Shares Held: 177,463,645
3 Mo. Net Change: -3,802,780
# New Positions: 44
# Closed Positions: 81
# Increased Positions: 260
# Reduced Positions: 309
# Net Buyers: -49

Officers & Directors

Name Age Since Current Position

Jean-Jacques Bienaime

65 2015 Chairman of the Board, Chief Executive Officer

Daniel Spiegelman

60 2012 Chief Financial Officer, Executive Vice President

Henry Fuchs

61 2016 President - Worldwide Research & Development

G. Eric Davis

48 2016 Executive Vice President, General Counsel, Secretary

Jeff Ajer

56 2013 Executive Vice President, Chief Commercial Officer

Robert Baffi

64 2009 Executive Vice President - Technical Operations

Brian Mueller

45 2016 Senior Vice President - Finance, Chief Accounting Officer

Lon Cardon

2019 Chief Scientific Strategy Officer

Richard Meier

59 2015 Lead Independent Director

Liz Anderson

2019 Director

Elizabeth Anderson

2019 Independent Director

Willard Dere

65 2016 Independent Director

Michael Grey

66 2005 Independent Director

Elaine Heron

71 2002 Independent Director

Robert Hombach

53 2017 Independent Director

V. Bryan Lawlis

67 2007 Independent Director

Alan Lewis

73 2005 Independent Director

David Pyott

65 2016 Independent Director

Dennis Slamon

70 2014 Independent Director